To assess the bleeding complications following immunization and its management
Not Applicable
- Conditions
- Health Condition 1: D67- Hereditary factor IX deficiencyHealth Condition 2: D66- Hereditary factor VIII deficiency
- Registration Number
- CTRI/2024/04/066207
- Lead Sponsor
- Manipal College of Nursing
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
• Patients with hemophilia of any age group.
• Patients who have received immunizations.
• Patients with history of admission to KH, Manipal
Exclusion Criteria
i)History of allergic reactions to immunizations.
ii) Patients taking anticoagulants.
iii) Patients who are unable to provide informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insight on the bleeding complications following immunization in hemophilia patients.Timepoint: 4 weeks to 6 weeks
- Secondary Outcome Measures
Name Time Method insight on prophylactic measures to prevent bleeding complications.Timepoint: 24 HOURS